Novo Nordisk Says Eli Lilly Used Misleading Weight Loss Drug Advertising. It's Suing
- Posted on July 21, 2026
- By International Business Times
- 0 Views
- 1 min read
In brief
Generating AI summary…
Novo Nordisk Says Eli Lilly Used Misleading Weight Loss Drug Advertising. It's Suing
The lawsuit, filed Tuesday, alleges that Eli Lilly violated federal and state false advertising laws by promoting "knowingly outdated clinical trial" results that compare both companies' drugs.